Cargando…

Upregulation of Protein Tyrosine Phosphatase Type IVA Member 3 (PTP4A3/PRL-3) is Associated with Tumor Differentiation and a Poor Prognosis in Human Hepatocellular Carcinoma

BACKGROUND: Protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3), a metastasis-associated phosphatase, plays multiple roles in cancer metastasis. We investigated PTP4A3/PRL-3 expression and its correlation with the clinicopathological features and prognosis in hepatocellular carcinoma (HCC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayinuer, Abudureheman, Yasen, Mahmut, Mogushi, Kaoru, Obulhasim, Gulanbar, Xieraili, Maimaiti, Aihara, Arihiro, Tanaka, Shinji, Mizushima, Hiroshi, Tanaka, Hiroshi, Arii, Shigeki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Hepatobiliary Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528959/ https://www.ncbi.nlm.nih.gov/pubmed/23064776 http://dx.doi.org/10.1245/s10434-012-2395-2

Ejemplares similares

Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy
por: Sucher, Robert, et al.
Publicado: (2020)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306
por: Modest, Dominik Paul, et al.
Publicado: (2020)

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011)

Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
por: Ayez, Ninos, et al.
Publicado: (2011)

Surgical Treatment of Renal Cell Cancer Liver Metastases: A Population-Based Study
por: Ruys, Anthony T., et al.
Publicado: (2011)

Mini-Mesohepatectomy for Colorectal Metastasis Invading the Middle Hepatic Vein at the Hepatocaval Confluence: Educational Video Demonstrating IOUS Use in Modern Hepatic Surgery
por: Makuuchi, Masatoshi, et al.
Publicado: (2009)

Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics
por: Zeng, Wenjiao, et al.
Publicado: (2010)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

Preoperative Imaging of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Meta-Analysis
por: van Kessel, Charlotte S., et al.
Publicado: (2012)

Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases
por: de Haas, Robbert J., et al.
Publicado: (2010)

Regenerative Nodular Hyperplasia of the Liver Related to Chemotherapy: Impact on Outcome of Liver Surgery for Colorectal Metastases
por: Wicherts, Dennis A., et al.
Publicado: (2010)

Risk Factors of Peritoneal Recurrence and Outcome of Resected Peritoneal Recurrence After Liver Resection in Hepatocellular Carcinoma: Review of 1222 Cases of Hepatectomy in a Tertiary Institution
por: Kow, Alfred Wei Chieh, et al.
Publicado: (2012)

Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis
por: Robinson, Stuart M., et al.
Publicado: (2012)

Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy
por: Ariizumi, Shun-ichi, et al.
Publicado: (2014)

Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2012)

Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma
por: Mantel, Hendrik T. J., et al.
Publicado: (2015)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
por: Meyer, Jeffrey J., et al.
Publicado: (2015)

The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer
por: Grąt, Michał, et al.
Publicado: (2016)

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy
por: Coelen, Robert J. S., et al.
Publicado: (2016)

Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis
por: Galjart, Boris, et al.
Publicado: (2016)

Patterns of Recurrence After Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer
por: Hagness, Morten, et al.
Publicado: (2013)

Parenchyma-Sparing Hepatectomy with Vascular Reconstruction Techniques for Resection of Colorectal Liver Metastases with Major Vascular Invasion
por: Ko, Saiho, et al.
Publicado: (2016)

Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
por: Grąt, Michał, et al.
Publicado: (2017)

Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis
por: Klompmaker, Sjors, et al.
Publicado: (2019)

The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy
por: Pereyra, D., et al.
Publicado: (2019)

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma
por: Olthof, Pim B., et al.
Publicado: (2020)

ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study
por: Li, Jun, et al.
Publicado: (2020)

Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease
por: de Savornin Lohman, Elise A. J., et al.
Publicado: (2019)

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands
por: Buisman, Florian E., et al.
Publicado: (2019)

Prognostic Relevance of a Complete Pathologic Response in Liver Transplantation for Hepatocellular Carcinoma
por: Grąt, Michał, et al.
Publicado: (2019)

The Landmark Series: Minimally Invasive Pancreatic Resection
por: van Hilst, Jony, et al.
Publicado: (2020)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study
por: Kuipers, H., et al.
Publicado: (2020)

Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy
por: Buisman, Florian E., et al.
Publicado: (2020)

Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer
por: Fromer, Marc W., et al.
Publicado: (2021)

Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry
por: Giuliante, Felice, et al.
Publicado: (2021)

Prediction of Early Recurrence After Surgery for Liver Tumor (ERASL): An International Validation of the ERASL Risk Models
por: Beumer, Berend R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0smpfq10po84kddv7lo8s52l1